Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...
Two years after Gilead Sciences secured the first option on Assembly Biosciences’ entire pipeline, the pharma has decided to pick the first fruits from the pact. Gilead is paying $35 million upfront ...
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its ...
– Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent Genital Herpes in 25 Years – FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.
US Health Agency Announces Two Medicare Pilot Programs on Drug Pricing Dec 19 (Reuters) - The U.S. government on Friday announced pilot programs to start in 2026 and 2027 that are aimed at reducing ...
Jonah Kaplan is an award-winning journalist who has built a strong reputation for his balanced reporting, thoughtful interviews, and deeply researched coverage of high-impact issues affecting the ...
Homeland Security Secretary Kristi Noem said President Trump had ordered the program to be suspended after it emerged that the shooting suspect had used it to obtain a green card. By Madeleine Ngo and ...
Ottawa is cancelling the intakes of two economic immigration programs in its attempt to manage backlogs and reduce immigration levels. Nicholas Keung is a Toronto-based reporter covering immigration ...
WETA in Washington, D.C., and its news and public affairs hub PBS News announced the two weekend programs that will replace PBS News Weekend in January. Horizons will premiere Saturday, Jan. 17, at 6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback